Therefore, in addition to recombinant full-length α-synuclein protein, we used a panel of peptides, including these common PTMs and critical fragments as antigen baits for the recovery of α-synuclein antibodies from PD patient samples (Table S1). The gene discussed is SNCA; the disease is Parkinson disease.